Stocknear Logo Stocknear
/
Popular
  • KO Coca Cola Company Stock
  • TSLA Tesla Inc Stock
  • AMD Advanced Micro Devices Stock
  • SPY SPDR S&P 500 ETF Trust ETF
  • NVDA Nvidia Stock
    • Login

    VBI Vaccines Inc.

    NASDAQ: VBIV · Real-Time Price · USD
    0.07
    -0.06 (-47.33%)
    At close: Aug 07, 2024, 8:00 PM

    VBI Vaccines Statistics

    Share Statistics

    VBI Vaccines has 28.68M shares outstanding. The number of shares has increased by 0% in one year.

    Shares Outstanding

    n/a
    		 28.68M

    Shares Change (YoY)

    n/a
    		 0%

    Shares Change (QoQ)

    n/a
    		 0%

    Owned by Institutions (%)

    n/a
    		 0%

    Shares Floating

    n/a
    		 n/a

    Failed to Deliver (FTD) Shares

    n/a
    		 269,628

    FTD / Avg. Volume

    n/a
    		 3.21%

    Short Selling Information

    Short Interest

    n/a
    		 n/a

    Short % of Shares Out

    n/a
    		 n/a

    Short % of Float

    n/a
    		 n/a

    Short Ratio (days to cover)

    n/a
    		 n/a

    Valuation Ratios

    The PE ratio is -0.1 and the forward PE ratio is null. VBI Vaccines's PEG ratio is 0.

    PE Ratio

    n/a
    		 -0.1

    Forward PE

    n/a
    		 n/a

    PS Ratio

    n/a
    		 1.05

    Forward PS

    n/a
    		 n/a

    PB Ratio

    n/a
    		 1.22

    P/FCF Ratio

    n/a
    		 -0.15

    PEG Ratio

    n/a
    		 0
    Financial Ratio History

    Enterprise Valuation

    VBI Vaccines has an Enterprise Value (EV) of 38.5M.

    EV / Sales

    n/a
    		 4.43

    EV / EBITDA

    n/a
    		 -0.72

    EV / EBIT

    n/a
    		 -0.63

    EV / FCF

    n/a
    		 -0.62

    Financial Position

    The company has a current ratio of 0.48, with a Debt / Equity ratio of 7.05.

    Current Ratio

    n/a
    		 0.48

    Quick Ratio

    n/a
    		 0.37

    Debt / Equity

    n/a
    		 7.05

    Debt / EBITDA

    n/a
    		 -0.99

    Debt / FCF

    n/a
    		 -0.86

    Interest Coverage

    n/a
    		 -6.86

    Financial Efficiency

    Return on Equity is -1233.37% and Return on Invested Capital is -93.11%.

    Return on Equity

    n/a
    		 -1233.37%

    Return on Assets

    n/a
    		 -106.77%

    Return on Invested Capital

    n/a
    		 -93.11%

    Revenue Per Employee

    n/a
    		 $66,274.81

    Profits Per Employee

    n/a
    		 $-708,671.76

    Employee Count

    n/a
    		 131

    Asset Turnover

    n/a
    		 0.1

    Inventory Turnover

    n/a
    		 1.71

    Taxes

    Income Tax

    n/a
    		 1.82M

    Effective Tax Rate

    n/a
    		 -1.96%

    Stock Price Statistics

    The stock price has increased by -88.14% in the last 52 weeks. The beta is 2.17, so VBI Vaccines's price volatility has been higher than the market average.

    Beta

    n/a
    		 2.17

    52-Week Price Change

    n/a
    		 -88.14%

    50-Day Moving Average

    n/a
    		 0.35

    200-Day Moving Average

    n/a
    		 0.55

    Relative Strength Index (RSI)

    n/a
    		 21.98

    Average Volume (20 Days)

    n/a
    		 8,393,583

    Income Statement

    In the last 12 months, VBI Vaccines had revenue of 8.68M and earned -92.84M in profits. Earnings per share was -5.96.

    Revenue

    n/a
    		 8.68M

    Gross Profit

    n/a
    		 -5.82M

    Operating Income

    n/a
    		 -55.31M

    Net Income

    n/a
    		 -92.84M

    EBITDA

    n/a
    		 -53.32M

    EBIT

    n/a
    		 -84.77M

    Earnings Per Share (EPS)

    n/a
    		 -5.96
    Full Income Statement

    Balance Sheet

    The company has 23.68M in cash and 53.04M in debt, giving a net cash position of -29.36M.

    Cash & Cash Equivalents

    n/a
    		 23.68M

    Total Debt

    n/a
    		 53.04M

    Net Cash

    n/a
    		 -29.36M

    Retained Earnings

    n/a
    		 -582.45M

    Total Assets

    n/a
    		 75.44M

    Working Capital

    n/a
    		 -51.23M
    Full Balance Sheet

    Cash Flow

    In the last 12 months, operating cash flow was -60.88M and capital expenditures -867K, giving a free cash flow of -61.75M.

    Operating Cash Flow

    n/a
    		 -60.88M

    Capital Expenditures

    n/a
    		 -867K

    Free Cash Flow

    n/a
    		 -61.75M

    FCF Per Share

    n/a
    		 -3.97
    Full Cash Flow Statement

    Margins

    Gross margin is -66.98%, with operating and profit margins of -637.08% and -1069.29%.

    Gross Margin

    n/a
    		 -66.98%

    Operating Margin

    n/a
    		 -637.08%

    Pretax Margin

    n/a
    		 -1069.29%

    Profit Margin

    n/a
    		 -1069.29%

    EBITDA Margin

    n/a
    		 -614.16%

    EBIT Margin

    n/a
    		 -637.08%

    FCF Margin

    n/a
    		 -711.24%

    Dividends & Yields

    VBIV does not appear to pay any dividends at this time.

    Dividend Per Share

    n/a
    		 n/a

    Dividend Yield

    n/a
    		 n/a

    Dividend Growth (YoY)

    n/a
    		 n/a

    Payout Ratio

    n/a
    		 n/a

    Earnings Yield

    n/a
    		 -1014.73%

    FCF Yield

    n/a
    		 -674.95%
    Dividend Details

    Analyst Forecast

    Currently there are no analyst rating for VBIV.

    Price Target

    n/a
    		 n/a

    Price Target Difference

    n/a
    		 n/a

    Analyst Consensus

    n/a
    		 n/a

    Analyst Count

    n/a
    		 n/a
    Stock Forecasts

    Fair Value

    There are several formulas that can be used to estimate the intrinsic value of a stock.

    Lynch Fair Value

    n/a
    		 n/a

    Lynch Upside

    n/a
    		 n/a

    Graham Number

    n/a
    		 n/a

    Graham Upside

    n/a
    		 n/a

    Stock Splits

    The last stock split was on Apr 12, 2023. It was a backward split with a ratio of 1:30.

    Last Split Date

    n/a
    		 Apr 12, 2023

    Split Type

    n/a
    		 backward

    Split Ratio

    n/a
    		 1:30

    Scores

    Altman Z-Score

    n/a
    		 -15.51

    Piotroski F-Score

    n/a
    		 4

    Add to Watchlist